槐耳颗粒治疗非小细胞肺癌术后临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R273

基金项目:


Clinical Study on Huaier Granules in the Treatment of Non-Small Cell Lung Cancer After Surgery
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察槐耳颗粒治疗非小细胞肺癌术后的疗效。方法:选取2021年10月—2024年10月德清 县人民医院收治的98例非小细胞肺癌患者,按治疗方案差异分为对照组50例及联合组48例。对照组予以胸腔 镜肺癌根治术,联合组在对照组基础上加用槐耳颗粒治疗,21天为1个周期,持续治疗3个周期。比较2组临 床疗效,比较2组治疗前后中医证候积分、生活质量评分[肺癌治疗功能评价表(FACT-L)]、免疫指标值[T淋 巴细胞(CD4+、CD8+、CD4+/CD8+)、自然杀伤(NK) 细胞]、炎症指标值[NOD样受体蛋白3(NLRP3)、白细 胞介素-4 (IL-4)、凋亡相关斑点样蛋白(ASC)]、肿瘤标志物[癌胚抗原(CEA)、鳞状细胞癌相关抗 原(SCC-Ag)、神经元特异性烯醇化酶(NSE)] 的变化。结果:治疗后,联合组总有效缓解率及总有效控制 率均高于对照组,差异均有统计学意义(P<0.05)。治疗后,2组咳嗽气促、神疲乏力、痰中带血中医证候积 分均较治疗前下降(P<0.05),FACT-L评分均较治疗前上升(P<0.05);联合组呼吸气促、神疲乏力、痰中 带血中医证候积分均低于对照组(P<0.05),FACT-L评分高于对照组(P<0.05)。治疗后,2组CD4+、NK、 CD4+/CD8+指标值均较治疗前升高,联合组治疗前后比较,差异有统计学意义(P<0.05);联合组CD4+、NK、 CD4+/CD8+指标值均高于对照组(P<0.05)。治疗后,2组NLRP3、IL-4、ASC指标值均较治疗前升高(P< 0.05),联合组上述3项指标值均小于对照组(P<0.05)。治疗后,2组CEA、SCC-Ag、NSE水平均较治疗前下 降(P<0.05),联合组上述3项水平均低于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意 义(P>0.05)。结论:槐耳颗粒治疗非小细胞肺癌术后疗效确切,可提升患者免疫力,减轻炎症反应,提高生 活质量。

    Abstract:

    Abstract:Objective:To observe the curative effect of Huaier Granules in the treatment of non-small cell lung cancer after surgery. Methods: A total of 98 patients with non-small cell lung cancer admitted to Deqing County People's Hospital from October 2021 to October 2024 were selected and divided into the control group (50 cases) and the combination group (48 cases) according to different treatment plans. The control group was treated with videoassisted thoracoscopic surgery (VATS) anatomic resection for lung cancer,and the combination group was additionally treated with Huaier Granules based on the treatment in the control group. With 21 days as a cycle,continuous treatment for 3 cycles was given. The clinical efficacy,and the changes in traditional Chinese medicine syndrome scores,quality of life scores [Functional Assessment of Cancer Therapy-Lung (FACT-L)], levels of immune indexes[T lymphocytes (CD4+ , CD8+ , CD4+/CD8+), natural killer (NK) cells], levels of inflammatory markers [NOD-like receptor thermal protein domain associated protein 3 (NLRP3),interleukin-4 (IL-4),apoptosis-associated specklike protein containing a CARD (ASC)],tumor markers [carcinoembryonic antigen (CEA),squamous cell carcinoma antigen( SCC-Ag),neuron-specific enolase( NSE)] before and after treatment were respectively compared between the two groups. Results: After treatment, the total effective remission rate and total effective control rate in the combination group were higher than those in the control group,differences being significant( P<0.05). After treatment, the traditional Chinese medicine syndrome scores of shortness of breath,spiritless fatigue and blood-steaked phlegm in the two groups were decreased when compared with those before treatment (P<0.05), and the FACT-L scores were increased when compared with those before treatment (P<0.05); the above three traditional Chinese medicine syndrome scores in the combination group were lower than those in the control group (P<0.05),and the FACT-L score was higher than that in the control group (P<0.05). After treatment,the levels of CD4+,NK,and CD4+/CD8+ in the two groups were up-regulated when compared with those before treatment,and there was significance being found in the comparison before and after treatment in the combination group (P<0.05);the levels of CD4+,NK,and CD4+/CD8+ in the combination group were higher than those in the control group (P<0.05). After treatment,the levels of NLRP3, IL-4,and ASC in the two groups were elevated when compared with those before treatment (P<0.05),and the levels of the above three indexes in the combination group were lower than those in the control group (P<0.05). After treatment, the levels of CEA, SCC-Ag, and NSE in the two groups were reduced when compared with those before treatment (P<0.05),and the above levels of the three indexes in the combination group were lower than those in the control group (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion:Huaier Granules have a definite curative effect on non-small cell lung cancer after surgery, which can improve the immunity of patients, reduce the inflammatory responses, and improve the quality of life.

    参考文献
    相似文献
    引证文献
引用本文

姚贇涛,吴云红.槐耳颗粒治疗非小细胞肺癌术后临床研究[J].新中医,2026,58(1):115-119

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-01-12
  • 出版日期:
文章二维码